hepatitis C

Bristol-Myers Hepatitis C Combo Therapy Shows Promise

Bristol-Myers Hepatitis C Combo Therapy Shows Promise

Bloomberg

Gilead Climbs on Study Results of Hepatitis C Combo

Gilead Climbs on Study Results of Hepatitis C Combo

Bloomberg

Abbott Presents Promising Phase 2b Interferon-free Hepatitis C Results at 2012 Liver Meeting®

Abbott Presents Promising Phase 2b Interferon-free Hepatitis C Results at 2012 Liver Meeting®

Yahoo/PR NewsWire

India Revokes Patent On Roche Hepatitis C Drug

India Revokes Patent On Roche Hepatitis C Drug

Pharmalot

For Hep C Investors, What Goes Around Comes Around

For Hep C Investors, What Goes Around Comes Around

Motley Fool

Vertex sinks as Incivek sales decline further

Vertex sinks as Incivek sales decline further

Yahoo/AP

Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover

Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover

Bloomberg

Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C

Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C

The Fly on the Wall

BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA

BioCryst Provides Update Regarding BCX5191 Development Plan Following Discussion With FDA

Yahoo

Vertex Draws Collaboration Interest For Hepatitis C Combo

Vertex Draws Collaboration Interest For Hepatitis C Combo

Bloomberg